Results 41 to 50 of about 3,875 (181)
Table_1_The Role of SETBP1 in Gastric Cancer: Friend or Foe.pdf
BackgroundGastric cancer (GC) remains a common disease with a poor prognosis worldwide. The SET binding protein 1 (SETBP1) has been implicated in the pathogenesis of several cancers and plays a dual role as an oncogene and a tumor suppressor gene ...
Qiong Li (346270) +5 more
core +1 more source
Chronic myelomonocytic leukemia (CMML) is a clonal myeloid neoplasm characterized by sustained monocytosis and mutations in TET2, ASXL1, SRSF2, SETBP1, NRAS, and KRAS. We describe a rare case of CSF3R T618I mutated CMML that has a proliferative phenotype,
Adelaide Kwon +6 more
doaj +1 more source
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS [PDF]
Mutations in ASXL1 are frequent in patients with myelodysplastic syndrome (MDS) and are associated with adverse survival, yet the molecular pathogenesis of ASXL1 mutations (ASXL1-MT) is not fully understood. Recently, it has been found that deletion of Asxl1 or expression of C-terminal-truncating ASXL1-MTs inhibit myeloid differentiation and induce MDS-
Inoue, Daichi +18 more
openaire +2 more sources
Image_2_The Role of SETBP1 in Gastric Cancer: Friend or Foe.tif
BackgroundGastric cancer (GC) remains a common disease with a poor prognosis worldwide. The SET binding protein 1 (SETBP1) has been implicated in the pathogenesis of several cancers and plays a dual role as an oncogene and a tumor suppressor gene ...
Qiong Li (346270) +5 more
core +1 more source
ÖzetAmaç: Mental retardasyon genetik ve çevresel faktörlerin etkilileri sonucu ortaya çıkan konjenital anomalilerdir. Genetik bozuklukların Mental retardasyonun gelişmesindeki etkinliği göz önüne alındığında genetik tanın hastalığın teşhisi ve ...
Meryem Alagoz, Ezgi Gunger, Adnan Yuksel
doaj +1 more source
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms
Therapy-related myeloid neoplasms (t-MN) are myeloid disorders, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) developing in patients treated with radiotherapy and/or chemotherapy for cancer or autoimmune diseases.
Emiliano Fabiani +5 more
doaj +5 more sources
SETBP1 mutation analysis in 944 patients with MDS and AML [PDF]
Germline mutations in SET binding protein 1 (SETBP1) have been reported in children with Schinzel–Giedion syndrome, a congenital condition characterized by facial as well as skull abnormalities, hydronephrosis and developmental delay.1 Recently, exome sequencing identified recurrent somatic mutations in SETBP1 in atypical chronic myeloid leukemia (aCML)
F, Thol +17 more
openaire +2 more sources
Image_1_The Role of SETBP1 in Gastric Cancer: Friend or Foe.tif
BackgroundGastric cancer (GC) remains a common disease with a poor prognosis worldwide. The SET binding protein 1 (SETBP1) has been implicated in the pathogenesis of several cancers and plays a dual role as an oncogene and a tumor suppressor gene ...
Qiong Li (346270) +5 more
core +1 more source
Abstract Mutations in SETBP1 are associated with adverse prognosis in myeloid malignancies. These mutations stabilize the SETBP1 protein, driving increased expression of a progenitor-associated gene expression program through incompletely described mechanisms.
Hanqian L. Carlson +14 more
openaire +2 more sources
Background Schinzel-Giedion syndrome (SGS) is a multiple malformation syndrome mainly characterized by severe intellectual disability, distinctive facial features, and multiple congenital anomalies, including skeletal abnormalities, genitourinary and ...
Maria Pia Leone +12 more
doaj +1 more source

